Fluxes and origin of halogenated organic trace gases from Momotombo volcano (Nicaragua)

In order to assess the contribution of quiescent degassing volcanoes to the global halo(hydro)carbon inventory, we have quantified volcanic fluxes of methyl halides (CH3Cl, CH3Br, and CH3I), ethyl halides (C2H5Cl, C2H5Br, and C2H5I), and higher chlorinated methanes (CH2Cl2, CHCl3, and CCl4). About every eight months over a 2-year period (July 2001 to July 2003), gas samples were collected and analyzed from high-temperature fumaroles (472°C–776°C) at the Nicaraguan subduction zone volcano Momotombo. Using a simultaneous record of trace and main compounds in fumarolic gases as well as SO2 fluxes of the plume, we were able to calculate halo(hydro)carbon fluxes for Momotombo and extrapolate our results to estimate halo(hydro)carbon fluxes for the whole Quaternary Nicaraguan volcanic arc and, in addition, for all volcanoes globally. The most abundant halohydrocarbon was CH3Cl with concentrations up to 19 ppmv. Further major halo(hydro)carbons were CH3Br, CH3I, CH2Cl2, CHCl3, CCl4, C2H5Cl, C2H5Br, C2H5I, and C2H3Cl with an average concentration of 0.20 to 720 ppbv. Estimated mean halo(hydro)carbon fluxes from Momotombo were in the range of 630–5000 g/yr for methyl halides, 49–260 g/yr for ethyl halides, and 2.4–24 g/yr for higher chlorinated methanes. When the results for Momotombo are scaled up to SO2 fluxes of the Nicaraguan volcanic transect, fluxes of 1.7 × 105 g/yr CH3Cl and 82 g/yr CCl4 are attained for Nicaragua. Scaled up to the estimated global SO2 flux, this translates to hypothetical global fluxes of 5.6 × 106 g/yr CH3Cl and 2.7 × 103 g/yr CCl4. These volcanic fluxes are negligible compared to global anthropogenic and natural emissions of about 3 × 1012 g/yr CH3Cl and 2 × 1010 g/yr CCl4

Counter-Gradient Variation in Respiratory Performance of Coral Reef Fishes at Elevated Temperatures

The response of species to global warming depends on how different populations are affected by increasing temperature throughout the species' geographic range. Local adaptation to thermal gradients could cause populations in different parts of the range to respond differently. In aquatic systems, keeping pace with increased oxygen demand is the key parameter affecting species' response to higher temperatures. Therefore, respiratory performance is expected to vary between populations at different latitudes because they experience different thermal environments. We tested for geographical variation in respiratory performance of tropical marine fishes by comparing thermal effects on resting and maximum rates of oxygen uptake for six species of coral reef fish at two locations on the Great Barrier Reef (GBR), Australia. The two locations, Heron Island and Lizard Island, are separated by approximately 1200 km along a latitudinal gradient. We found strong counter-gradient variation in aerobic scope between locations in four species from two families (Pomacentridae and Apogonidae). High-latitude populations (Heron Island, southern GBR) performed significantly better than low-latitude populations (Lizard Island, northern GBR) at temperatures up to 5°C above average summer surface-water temperature. The other two species showed no difference in aerobic scope between locations. Latitudinal variation in aerobic scope was primarily driven by up to 80% higher maximum rates of oxygen uptake in the higher latitude populations. Our findings suggest that compensatory mechanisms in high-latitude populations enhance their performance at extreme temperatures, and consequently, that high-latitude populations of reef fishes will be less impacted by ocean warming than will low-latitude populations

A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale

Negative symptoms represent an unmet need of treatment in schizophrenia. Although a consensus exists on negative symptom construct, and second generation assessment instruments reflecting the consensus are available, studies still rely upon old assessment instruments, that do not reflect recent conceptualizations and might limit progress in the search for effective treatments. This is often the case in the European context, where one of the challenges encountered in designing large studies is the availability of validated instruments in the many languages of the continent. To address this challenge and promote sound research on negative symptoms in Europe, the ECNP Schizophrenia Network coordinated a large multicenter, multinational validation study of the Brief Negative Symptom Scale (BNSS). Clinically-stable subjects with schizophrenia (SCZ, N = 249) were recruited from 10 European Countries. Apart from BNSS, subjects were administered the Positive and Negative Syndrome Scale (PANSS) and standardized instruments for depression, extrapyramidal symptoms and psychosocial functioning. Results showed an excellent internal consistency, convergent and discriminant validity of BNSS and replicated a 5 factor-model. A larger number of subjects with predominant negative symptoms, i.e. the target population for clinical trials, was identified by using the BNSS compared to the PANSS. Regression analysis showed that BNSS-avolition, a key negative symptom poorly assessed by PANSS, explained 23.9% of psychosocial functioning, while no combination of the PANSS core negative symptoms showed the same impact on functioning. The study demonstrated that BNSS has substantial advantages with respect to PANSS for the identification of the avolition domain and subjects with predominant negative symptoms

3T3 Cell Lines Stably Expressing Pax6 or Pax6(5a) – A New Tool Used for Identification of Common and Isoform Specific Target Genes

Pax6 and Pax6(5a) are two isoforms of the evolutionary conserved Pax6 gene often co-expressed in specific stochiometric relationship in the brain and the eye during development. The Pax6(5a) protein differs from Pax6 by having a 14 amino acid insert in the paired domain, causing the two proteins to have different DNA binding specificities. Difference in functions during development is proven by the fact that mutations in the 14 amino acid insertion for Pax6(5a) give a slightly different eye phenotype than the one described for Pax6. Whereas quite many Pax6 target genes have been published during the last years, few Pax6(5a) specific target genes have been reported on. However, target genes identified by Pax6 knockout studies can probably be Pax6(5a) targets as well, since this isoform also will be affected by the knockout. In order to identify new Pax6 target genes, and to try to distinguish between genes regulated by Pax6 and Pax6(5a), we generated FlpIn-3T3 cell lines stably expressing Pax6 or Pax6(5a). RNA was harvested from these cell lines and used in gene expression microarrays where we identified a number of genes differentially regulated by Pax6 and Pax6(5a). A majority of these were associated with the extracellular region. By qPCR we verified that Ncam1, Ngef, Sphk1, Dkk3 and Crtap are Pax6(5a) specific target genes, while Tgfbi, Vegfa, EphB2, Klk8 and Edn1 were confirmed as Pax6 specific target genes. Nbl1, Ngfb and seven genes encoding different glycosyl transferases appeared to be regulated by both. Direct binding to the promoters of Crtap, Ctgf, Edn1, Dkk3, Pdgfb and Ngef was verified by ChIP. Furthermore, a change in morphology of the stably transfected Pax6 and Pax6(5a) cells was observed, and the Pax6 expressing cells were shown to have increased proliferation and migration capacities